Apollo Medical - AMEH Stock Forecast, Price & News

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Apollo Medical in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" AMEH shares.
View AMEH analyst ratings or view top-rated stocks.

3 equities research analysts have issued twelve-month target prices for Apollo Medical's shares. Their AMEH share price forecasts range from $57.00 to $60.00. On average, they anticipate the company's share price to reach $58.50 in the next twelve months. This suggests a possible upside of 49.8% from the stock's current price.
View analysts price targets for AMEH or view top-rated stocks among Wall Street analysts.

Apollo Medical's stock was trading at $29.59 on January 1st, 2023. Since then, AMEH shares have increased by 32.0% and is now trading at $39.05.
View the best growth stocks for 2023 here.

Apollo Medical saw a decline in short interest in the month of March. As of March 15th, there was short interest totaling 3,500,000 shares, a decline of 5.1% from the February 28th total of 3,690,000 shares. Based on an average daily trading volume, of 179,400 shares, the days-to-cover ratio is currently 19.5 days. Approximately 8.1% of the shares of the stock are short sold.
View Apollo Medical's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023.
View our AMEH earnings forecast.

Apollo Medical Holdings, Inc. (NASDAQ:AMEH) issued its earnings results on Thursday, November, 4th. The company reported $0.69 EPS for the quarter, beating analysts' consensus estimates of $0.34 by $0.35. The firm earned $227.12 million during the quarter. Apollo Medical had a net margin of 4.29% and a trailing twelve-month return on equity of 10.37%. During the same quarter in the previous year, the business earned $0.45 earnings per share.

ETFs with the largest weight of Apollo Medical (NASDAQ:AMEH) stock in their portfolio include Fidelity Digital Health ETF (FDHT), Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Services ETF (XHS), Invesco S&P SmallCap Quality ETF (XSHQ), Syntax Stratified SmallCap ETF (SSLY), iShares S&P Small-Cap 600 Value ETF (IJS), SPDR S&P 600 Small CapValue ETF (SLYV) and iShares U.S. Healthcare Providers ETF (IHF).

Apollo Medical updated its FY 2023 earnings guidance on Thursday, February, 23rd. The company provided EPS guidance of $0.95-$1.20 for the period, compared to the consensus EPS estimate of $0.97. The company issued revenue guidance of $1.30 billion-$1.50 billion, compared to the consensus revenue estimate of $1.23 billion.

15 employees have rated Apollo Medical Chief Executive Officer Thomas Lam on Glassdoor.com. Thomas Lam has an approval rating of 43% among the company's employees. This puts Thomas Lam in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. 28.0% of employees surveyed would recommend working at Apollo Medical to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Medical investors own include PayPal (PYPL), SEA (SE), Mastercard (MA), NVIDIA (NVDA), Walt Disney (DIS), Lululemon Athletica (LULU), Enphase Energy (ENPH), Main Street Capital (MAIN), Block (SQ) and Exxon Mobil (XOM).

Apollo Medical trades on the NASDAQ under the ticker symbol "AMEH."

Apollo Medical's stock is owned by many different retail and institutional investors. Top institutional investors include Geode Capital Management LLC (1.34%), Dimensional Fund Advisors LP (0.72%), Charles Schwab Investment Management Inc. (0.53%), Principal Financial Group Inc. (0.44%), Morgan Stanley (0.43%) and Legal & General Group Plc (0.17%). Insiders that own company stock include Adrian Vazquez, Albert Waichow Young, Brandon Sim, Eric Chin, Linda Marsh, Physicians Of Californi Allied and Thomas S Lam.
View institutional ownership trends.

Shares of AMEH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AMEH stock can currently be purchased for approximately $39.05.

Apollo Medical (NASDAQ:AMEH) has a market capitalization of $2.24 billion and generates $1.14 billion in revenue each year. The company earns $49.05 million in net income (profit) each year or $1.06 on an earnings per share basis.

The company employs 1,362 workers across the globe.

Apollo Medical's mailing address is 1668 S. GARFIELD AVENUE 2ND FLOOR, ALHAMBRA CA, 91801. The official website for the company is www.apollomed.net. The company can be reached via phone at (626) 282-0288, via email at investors@apollomed.net, or via fax at 818-839-5190.